Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis
-
Yoshihiro Noji
Abstract
To investigate the clinical significance of circulating matrix metalloproteinases (MMPs) and their tissue inhibitos (TIMPs) in patients with premature coronary atheroscrelosis, we studied 53 consecutive male patients with angiographically defined premature (<65 years) and stable coronary artery disease. Plasma levels of MMP-2, MMP-3, MMP-9, TIMP-1, and TIMP-2 were determined in peripheral blood by a sandwich enzyme immunoassay, and the results were compared with those from 133 age-matched control males. There were significant differences in all the MMPs and TIMPs (p<0.001) between patients and controls. In the patient group, the levels of MMP-9 (mean±SD (ng/ml) 27.2±15.2/21.8±15.2) and TIMP-1 (130.4±55.7/94.5±26.3) were significantly higher, and the levels of MMP-2 (632.5±191.6/727.6±171.4), MMP-3 (53.1±31.2/79.6± 29.9), and TIMP-2 (24.7±15.2/35.4±16.4) were significantly lower than those of controls. We found significant positive correlation between plasma MMP-9 levels and low-density lipoprotein (LDL)-cholesterol levels (Rs=0.168, p=0.022), and significant negative correlation between plasma MMP-9 levels and high-density lipoprotein (HDL)-cholesterol levels (Rs=−0.164, p=0.026) by Spearman rank correlation test. In contrast, plasma MMP-2 (Rs=0.181, p=0.014) and MMP-3 (Rs=0.260, p=0.0004) levels were positively correlated with HDL-cholesterol levels. TIMP-2 levels were negatively correlated with total cholesterol (Rs=−0.197, p=0.007) and LDL-cholesterol (Rs=−0.168, p=0.022) levels. These results suggest that the circulating levels of MMPs and TIMPs are altered in patients with premature coronary atherosclerosis and that plasma lipoprotein cholesterol levels correlate with these, possibly as a result of the lipoprotein-vessel wall interactions.
Copyright © 2001 by Walter de Gruyter GmbH & Co. KG
Articles in the same Issue
- SIBioC 2001 33rd National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology
- CCLM: The Near Future
- Granulocyte-Colony Stimulating Factor and Macrophage-Colony Stimulating Factor in Patients with Non-Small-Cell Lung Cancer
- Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis
- Real-Time Quantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) for the Measurement of Prostate-Specific Antigen mRNA in the Peripheral Blood of Patients with Prostate Carcinoma Using the TaqManTM Detection System
- Serum Cardiac Troponin I after Conventional and Minimal Invasive Coronary Artery Bypass Surgery
- Improvement of the Quantitative Method for Glucose Determination Using Hexokinase and Glucose 6-Phosphate Dehydrogenase
- Conditions for Single-Strand Conformation Polymorphism (SSCP) Analysis of BRCA1 Gene Using an Automated Electrophoresis Unit
- Discrepancies between Apolipoprotein E Phenotyping and Genotyping in the Elderly
- Markers of Bone Turnover in Postmenopausal Women Receiving Hormone Replacement Therapy
- Reference Intervals for the Markers of Proteinuria with a Standardised Bed-Rest Collection of Urine
- The Friedewald Formula Underestimates LDL Cholesterol at low Concentrations
- The White Blood Cell Differential: Three Methods Compared
- Plasma Brain Natriuretic Peptide Measured by Fully-Automated Immunoassay and by Immunoradiometric Assay Compared
- Length of Sedimentation Reaction in Undiluted Blood (Erythrocyte Sedimentation Rate): Variations with Sex and Age and Reference Limits
- Biochemical Analysis of the Sperm and Infertility
- Evaluation of a Rapid Bedside Immunochromatographic Assay for Detection of Cardiac Troponin I in Whole Blood
- Correct Graphic Presentation of Method Comparison Data
- European Symposium on Clinical Laboratory and In Vitro Diagnostics Industry
Articles in the same Issue
- SIBioC 2001 33rd National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology
- CCLM: The Near Future
- Granulocyte-Colony Stimulating Factor and Macrophage-Colony Stimulating Factor in Patients with Non-Small-Cell Lung Cancer
- Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis
- Real-Time Quantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) for the Measurement of Prostate-Specific Antigen mRNA in the Peripheral Blood of Patients with Prostate Carcinoma Using the TaqManTM Detection System
- Serum Cardiac Troponin I after Conventional and Minimal Invasive Coronary Artery Bypass Surgery
- Improvement of the Quantitative Method for Glucose Determination Using Hexokinase and Glucose 6-Phosphate Dehydrogenase
- Conditions for Single-Strand Conformation Polymorphism (SSCP) Analysis of BRCA1 Gene Using an Automated Electrophoresis Unit
- Discrepancies between Apolipoprotein E Phenotyping and Genotyping in the Elderly
- Markers of Bone Turnover in Postmenopausal Women Receiving Hormone Replacement Therapy
- Reference Intervals for the Markers of Proteinuria with a Standardised Bed-Rest Collection of Urine
- The Friedewald Formula Underestimates LDL Cholesterol at low Concentrations
- The White Blood Cell Differential: Three Methods Compared
- Plasma Brain Natriuretic Peptide Measured by Fully-Automated Immunoassay and by Immunoradiometric Assay Compared
- Length of Sedimentation Reaction in Undiluted Blood (Erythrocyte Sedimentation Rate): Variations with Sex and Age and Reference Limits
- Biochemical Analysis of the Sperm and Infertility
- Evaluation of a Rapid Bedside Immunochromatographic Assay for Detection of Cardiac Troponin I in Whole Blood
- Correct Graphic Presentation of Method Comparison Data
- European Symposium on Clinical Laboratory and In Vitro Diagnostics Industry
